Cyclosporine in severe childhood atopic dermatitis: A multicenter study
J. Berth‐Jones(Leicester Royal Infirmary), Robin Graham‐Brown(Leicester Royal Infirmary), John Harper(University College London), Michael J. Cork(Royal Hallamshire Hospital), Boon Chin Tan(University of Malaya), Sam Salek(University of Hertfordshire), B.R. Allen(St. Vincent Hospital), Irshad Zaki, Steven G. Smith(AstraZeneca (Netherlands)), R.D.R. Camp(St Thomas' Hospital), Peter S. Friedmann(University of Liverpool), S. Lewis‐Jones(Wrexham Maelor Hospital), A.Y. Finlay(Cardiff University), S.S. Bleehen(Royal Hallamshire Hospital), Helen Goodyear(Birmingham Children's Hospital)
Cited by 198
Related Papers
Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use
|Clinical and Experimental Dermatology|1994|5.5k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k
The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis..
|British Journal of Dermatology|1994|1.3k
The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use
|British Journal of Dermatology|2010|1k
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
|Nature Genetics|2012|1k